Product Information
FEBUXOSTAT 40 MG TABLET is a generic product labeled by Tris Pharma Inc, priced at $0.2128 per EA under NDC 27808020601. Its NADAC has been published 288 times since Dec 23, 2020.
Strength
40 mg/1
Manufacturer
Tris Pharma IncNDC
27808020601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FEBUXOSTATApproval Type
Generic (ANDA)
FDA Application
ANDA210292On Market Since
9/28/2020
Pharmacological Classes
Price Statistics
The NADAC for FEBUXOSTAT 40 MG TABLET has been published 288 times since Dec 23, 2020, and over the history we have for it it has declined 87.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2128 per EA |
|---|---|
| All-time high | $1.7240 (Jan 13, 2021) |
| All-time low | $0.2016 (Jan 21, 2026) |
| 52-week high | $0.3713 |
| 52-week low | $0.2016 |
| Median price | $0.5353 |
| Average price | $0.6192 |
| Largest weekly change | -29.6% (Apr 17, 2024) |
| Weeks tracked | 288 |
| Tracking since | Dec 23, 2020 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FEBUXOSTAT 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEBUXOSTAT 40 MG TABLET, manufactured by Tris Pharma Inc, is $0.2128 per EA (NDC 27808020601), effective Jun 24, 2026.
How has the price of FEBUXOSTAT 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for FEBUXOSTAT 40 MG TABLET has declined 87.7%. It has been tracked across 288 weekly CMS publications since Dec 23, 2020.
What are the highest and lowest recorded NADAC prices for FEBUXOSTAT 40 MG TABLET?
Since Dec 23, 2020, the NADAC for FEBUXOSTAT 40 MG TABLET has ranged from a low of $0.2016 (Jan 21, 2026) to a high of $1.7240 (Jan 13, 2021), with a median of $0.5353 per EA.
Are there cheaper alternatives to FEBUXOSTAT 40 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as FEBUXOSTAT 40 MG TABLET, but none are currently priced below it.
Who manufactures FEBUXOSTAT 40 MG TABLET?
FEBUXOSTAT 40 MG TABLET (NDC 27808020601) is labeled by Tris Pharma Inc, and CMS classifies it as a generic product.
Related Drugs
Same classification